rs557878787
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP5
The NM_020433.5(JPH2):c.1213G>T(p.Ala405Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,612,324 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A405T) has been classified as Uncertain significance.
Frequency
Consequence
NM_020433.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 17Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
 - cardiomyopathy, dilated, 2EInheritance: Unknown, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
 - hypertrophic cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
 - dilated cardiomyopathyInheritance: SD Classification: MODERATE Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000197  AC: 3AN: 152234Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.00000400  AC: 1AN: 249976 AF XY:  0.00000739   show subpopulations 
GnomAD4 exome  AF:  0.00000274  AC: 4AN: 1460090Hom.:  0  Cov.: 32 AF XY:  0.00000413  AC XY: 3AN XY: 726460 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000197  AC: 3AN: 152234Hom.:  0  Cov.: 33 AF XY:  0.0000269  AC XY: 2AN XY: 74382 show subpopulations 
ClinVar
Submissions by phenotype
not provided    Pathogenic:1Uncertain:1 
A likely pathogenic variant has been identified in the JPH2 gene. The A405S variant has been reported previously as a de novo variant in a 16-year-old male with HCM without atrial arrhythmias (Beavers et al., 2013). The A405S variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The A405S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, this variant is likely pathogenic. -
- -
Hypertrophic cardiomyopathy    Uncertain:1 
This sequence change replaces alanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 405 of the JPH2 protein (p.Ala405Ser). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 23973696, 31227780; internal data). ClinVar contains an entry for this variant (Variation ID: 372724). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects JPH2 function (PMID: 28393127). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype    Uncertain:1 
The p.A405S variant (also known as c.1213G>T), located in coding exon 3 of the JPH2 gene, results from a G to T substitution at nucleotide position 1213. The alanine at codon 405 is replaced by serine, an amino acid with similar properties. This variant was reported in individual(s) with features consistent with hypertrophic cardiomyopathy (HCM) (Beavers DL et al. J. Am. Coll. Cardiol., 2013 Nov;62:2010-9; Quick AP et al. JACC Basic Transl Sci, 2017 Feb;2:56-67; Ambry internal data). An animal model expressing the equivalent of this variant exhibited some features consistent with HCM (Quick AP et al. JACC Basic Transl Sci, 2017 Feb;2:56-67). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on available evidence to date, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at